Name | Number of supported studies | Average coverage | |
---|---|---|---|
renal alpha-intercalated cell | 7 studies | 55% ± 9% | |
ionocyte | 5 studies | 43% ± 15% |
Insufficient scRNA-seq data for expression of DMRT2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 94% | 238.52 | 545 / 578 | 42% | 7.36 | 486 / 1155 |
breast | 100% | 463.42 | 458 / 459 | 24% | 0.56 | 268 / 1118 |
brain | 77% | 93.45 | 2043 / 2642 | 42% | 1.63 | 295 / 705 |
kidney | 100% | 3246.12 | 89 / 89 | 13% | 20.96 | 117 / 901 |
muscle | 97% | 133.37 | 780 / 803 | 0% | 0 | 0 / 0 |
skin | 61% | 34.79 | 1101 / 1809 | 33% | 1.68 | 154 / 472 |
adipose | 92% | 288.17 | 1111 / 1204 | 0% | 0 | 0 / 0 |
intestine | 40% | 56.04 | 382 / 966 | 44% | 2.23 | 232 / 527 |
esophagus | 33% | 18.07 | 477 / 1445 | 37% | 4.42 | 68 / 183 |
uterus | 21% | 11.42 | 35 / 170 | 44% | 3.58 | 203 / 459 |
bladder | 14% | 4.76 | 3 / 21 | 33% | 2.04 | 167 / 504 |
tonsil | 0% | 0 | 0 / 0 | 42% | 3.21 | 19 / 45 |
eye | 0% | 0 | 0 / 0 | 36% | 1.55 | 29 / 80 |
stomach | 6% | 2.22 | 21 / 359 | 26% | 1.41 | 73 / 286 |
prostate | 30% | 23.02 | 73 / 245 | 1% | 0.02 | 4 / 502 |
thymus | 4% | 13.79 | 25 / 653 | 15% | 10.23 | 88 / 605 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.57 | 4 / 29 |
adrenal gland | 2% | 0.92 | 6 / 258 | 10% | 0.39 | 23 / 230 |
ovary | 1% | 0.33 | 2 / 180 | 9% | 0.41 | 37 / 430 |
blood vessel | 8% | 5.45 | 113 / 1335 | 0% | 0 | 0 / 0 |
heart | 6% | 2.63 | 52 / 861 | 0% | 0 | 0 / 0 |
pancreas | 1% | 0.31 | 3 / 328 | 3% | 0.09 | 6 / 178 |
liver | 0% | 0 | 0 / 226 | 3% | 0.12 | 13 / 406 |
peripheral blood | 1% | 0.32 | 6 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_2000287 | Biological process | positive regulation of myotome development |
GO_0048706 | Biological process | embryonic skeletal system development |
GO_0061055 | Biological process | myotome development |
GO_0007548 | Biological process | sex differentiation |
GO_0014807 | Biological process | regulation of somitogenesis |
GO_0008150 | Biological process | biological_process |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005575 | Cellular component | cellular_component |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0005515 | Molecular function | protein binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | DMRT2 |
Protein name | Doublesex- and mab-3-related transcription factor 2 (Doublesex-like 2 protein) (DSXL-2) Doublesex and mab-3 related transcription factor 2 DMRT2 protein (cDNA FLJ77088, highly similar to Homo sapiens doublesex and mab-3 related transcription factor 2 (DMRT2), transcript variant 1, mRNA) |
Synonyms | DSXL2 |
Description | FUNCTION: Transcriptional activator that directly regulates early activation of the myogenic determination gene MYF5 by binding in a sequence-specific manner to the early epaxial enhancer element of it. Involved in somitogenesis during embryogenesis and somite development and differentiation into sclerotome and dermomyotome. Required for the initiation and/or maintenance of proper organization of the sclerotome, dermomyotome and myotome (By similarity). . |
Accessions | ENST00000302441.7 ENST00000358146.7 [Q9Y5R5-1] Q9Y5R5 ENST00000412350.6 [Q9Y5R5-2] A0A0A0MR18 ENST00000635183.1 [Q9Y5R5-2] ENST00000382251.7 [Q9Y5R5-1] Q05C20 ENST00000259622.10 [Q9Y5R5-2] ENST00000382255.7 [Q9Y5R5-2] |